Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • aurobindo pharma

    Tag: aurobindo pharma

    You Searched For "aurobindo-pharma"
    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Medical Dialogues Bureau10 April 2020 7:30 AM GMT
    Hyderabad: Aurobindo Pharma Limited has announced that the Company has received the final approval from the US Food & Drug Administration (USFDA)...
    Aurobindo Pharma faces CA Suit in US for concealing facts

    Aurobindo Pharma faces CA Suit in US for concealing facts

    Medical Dialogues Bureau9 April 2020 8:06 AM GMT
    Hyderabad: A class-action suit has been filed against some drug manufacturers, including Aurobindo Pharma and Emcure Pharmaceuticals, in a USA court...
    Aurobindo, Sandoz call off 900 million US dollar deal

    Aurobindo, Sandoz call off 900 million US dollar deal

    Medical Dialogues Bureau2 April 2020 9:57 AM GMT
    New Delhi: Aurobindo Pharma on Thursday said the USD 900 million deal to acquire Sandoz Inc''s US-based generic oral solids and dermatology...
    NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir

    NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir

    Medical Dialogues Bureau29 March 2020 7:49 AM GMT
    New Delhi: The National Pharmaceuticals Pricing Authority (NPPA), Department of Pharmaceuticals directed 3 major manufacturers of the HIV Combo...
    Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal

    Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal

    Medical Dialogues Bureau26 Nov 2019 4:00 AM GMT
    In September 2018, the USD three billion drug-maker, Aurobindo Pharma said its US subsidiary entered into an agreement to acquire commercial...
    Aurobindo Pharma gets 14 USFDA observations for Pashamylaram facility

    Aurobindo Pharma gets 14 USFDA observations for Pashamylaram facility

    Farhat Nasim15 Nov 2019 6:43 AM GMT
    The US Food and Drug Administration (USFDA) inspected company's Unit IV, a general injectable formulation manufacturing facility situated at...
    Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore

    Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore

    Medical Dialogues Bureau14 Nov 2019 4:00 AM GMT
    Managing director of Aurobindo Pharma N Govindarajan said We had another quarter of healthy performance where we continued to grow in the US and...
    Aurobindo Pharma USA recalls heartburn drug Ranitidine over cancer causing impurities

    Aurobindo Pharma USA recalls heartburn drug Ranitidine over cancer causing impurities

    Medical Dialogues Bureau10 Nov 2019 4:15 AM GMT
    Aurobindo Pharma is second city-based drug company that has initiated the voluntary recall after the FDA announced an investigation into the reported...
    Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA

    Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA

    Medical Dialogues Bureau11 Oct 2019 4:30 AM GMT
    "The responsibilities and procedures applicable to the quality control unit are not fully followed. Several lists of documents requested were either...
    Aurobindo Pharma Unit-7 gets 7 USFDA observations

    Aurobindo Pharma Unit-7 gets 7 USFDA observations

    Medical Dialogues Bureau8 Oct 2019 9:24 AM GMT
    The United States Food and Drug Administration (USFDA) conducted a Current Good Manufacturing Practices (CGMP) inspection at the company's unit-7...
    Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

    Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

    Medical Dialogues Bureau23 Sep 2019 4:30 AM GMT
    Ranitidine is an Over-The-Counter (OTC) and prescription drug which decreases the amount of acid created by the stomach.Hyderabad: Dr Reddy's...
    CDSCO releases updated list of 2006 WHO GMP certified drug manufacturers; Details

    CDSCO releases updated list of 2006 WHO GMP certified drug manufacturers; Details

    Farhat Nasim6 Jun 2019 6:41 AM GMT
    New Delhi: The apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has recently released an updated list of WHO GMP...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X